La PI pour les entreprises en démarrage du secteur des sciences de la vie : protégez vos actifs les plus précieux (disponible en anglais)

55 minutes de lecture
08 juin 2022

For early-stage pharma and biotech companies, comprehensive intellectual property (IP) strategies do more than protect innovation. They set the stage for your company's long-term success – helping raise funds, attract partners and expand into new markets.

Our Vancouver IP Group has created a three-part video series to provide early-stage life sciences companies with the resources they need to ensure their IP assets are protected in a highly competitive market.

IP assets

Mark Wilke, partner and patent agent, gives an introduction into the various IP assets – patents, industrial designs/design patents, trademarks, copyrights and trade secrets – that are fundamental for life sciences companies.

Five IP considerations for startups

Sonia Ziesche, principal and chair of the Vancouver Life Sciences Group, and Edith Penty-Geraets, chartered (UK) patent attorney and European patent attorney, review a variety of factors that every startup company should take into account when creating an IP strategy. Topics include:

  • IP housekeeping
  • IP and employees
  • Cost forecasting
  • Patent application filing
  • Filing strategy

Strategies on how to build an IP portfolio for growth

Partner Lisa Thorne and associate Jayde Wood share practical tips for creating an IP portfolio that will distinguish life sciences companies apart from their competitors in the industry. This video will help companies recognize the different types of IP protection, as well as how to align their IP strategy to advance their business goals.

Are you ready to take your IP strategy to the next level? We can help.

After watching the videos, you will have questions about obtaining, protecting and maximizing IP assets. Let us give you those answers. Contact one of our IP practitioners by filling out the form below to schedule a complimentary 30-minute discussion, where we will learn about your company's requirements and understand how we can help develop the right IP strategy for your business.

CECI NE CONSTITUE PAS UN AVIS JURIDIQUE. L'information qui est présentée dans le site Web sous quelque forme que ce soit est fournie à titre informatif uniquement. Elle ne constitue pas un avis juridique et ne devrait pas être interprétée comme tel. Aucun utilisateur ne devrait prendre ou négliger de prendre des décisions en se fiant uniquement à ces renseignements, ni ignorer les conseils juridiques d'un professionnel ou tarder à consulter un professionnel sur la base de ce qu'il a lu dans ce site Web. Les professionnels de Gowling WLG seront heureux de discuter avec l'utilisateur des différentes options possibles concernant certaines questions juridiques précises.

Sujet(s) similaire(s)   Sciences de la vie